Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
accomplish, afflicted, Algorx, AmerisourceBergen, ample, Anecdotal, ascertain, auction, blinded, Brian, captionIn, captionSavient, capture, Cardinal, carryforward, carve, catabolism, cGCP, citizen, commonly, concomitantly, consignment, core, Counter, coupled, credible, debarred, delete, denial, depriving, derecognition, description, disagreement, dossier, drafted, duly, Dutch, Elitra, EMEA, enjoining, eradication, exidase, FileNo, fit, formal, Frameworkissued, FSP, Hamelin, Hamelinjoined, Hayden, Haydenjoined, Heller, illustrated, inactive, inadvertently, Ingleby, inInternal, Inland, inRule, jointly, Lee, licensor, lifting, line, logo, McGladrey, McKesson, meant, Megase, Mexico, midpoint, monetization, neighboring, Neurotech, NOL, nonvested, Officersin, ofForm, omitted, onForm, ordinary, outlay, outlined, overcharged, Paul, PDA, percent, Pharmacist, photographic, polymer, pool, probenecid, prolonged, pronouncement, proven, Pullen, quantification, quantify, Quantifying, read, recast, recommence, reconciled, reconsideration, Reed, regression, relieve, restrain, restraining, rollforward, satisfactorily, Simon, simplified, stay, store, stored, strictly, stronger, subsidized, subtenant, superceded, tabular, temporarily, thereunto, thinner, thisForm, threshold, undersigned, unrecognized, unusual, Upsher, variance, Watson, web
Removed:
accelerated, accept, account, addressed, agent, akzo, allocation, amend, amortizing, Andersen, anniversary, annually, appointment, Arab, ARB, Arthur, assembled, assigned, assumed, auditor, avoiding, book, borrowing, calculate, cancelable, cancer, capability, caption, cardiovascular, carried, central, commencing, compare, complement, component, composition, consumption, convert, convertible, cover, custom, cycle, deemed, deficiency, delinquent, demanding, depending, derive, diabetic, discounted, disseminate, divided, efficiently, EITF, elderly, emerging, Employer, eventual, excluding, executed, exempt, exist, existence, explore, export, facing, familiarity, fiduciary, filer, fill, financed, fix, Fleetwood, frail, freight, Fulbright, furniture, GMP, grow, growing, guaranteed, handle, Hapoalim, healing, hedging, holding, Home, hypothetical, identification, iii, immunology, impacted, improve, IMS, inadequately, informal, infrastructure, initiated, Insider, inspected, inspection, instrument, intolerant, introductory, investing, iv, Jaworski, knee, labor, leader, leading, LIBOR, list, loan, loaned, malnutrition, mark, matching, measurable, medication, methodology, MHRA, mix, neurologic, neuropathic, neuropathy, Nobel, outlook, overstatement, pediatric, pension, pensionable, periodically, peripheral, permanently, personal, pill, pipeline, practicable, practical, preceding, preference, prepaid, prevail, priority, proceed, pursuit, quantity, quickly, range, recessionary, regional, reinvested, reliably, relocation, replace, residual, resigned, responsive, reverse, reversed, ruling, run, scheduled, sealant, shipped, skin, south, staffing, stating, step, supplement, supplemental, surgical, Synvisc, tamoxifen, tangible, Task, telephone, thereto, Thornton, treated, treating, unaudited, underperformance, undertaken, undistributed, unfavorable, unfunded, unique, unlicensed, upfront, upgrade, upgrading, viable, whichever, wholly, world, worth, wound, wrongdoing
Filing tables
Filing exhibits
- 10-K Annual report
- 10.8 EX-10.8: Amended and Restated Savient Pharmaceuticals, Inc. 1998 Employee Stock Purchase Plan
- 10.18 EX-10.18: Amendment to the Employment Agreement with Zebulun D. Horowitz, M.D.
- 10.19 EX-10.19: Form of Senior Management Incentive Stock Option Agreement
- 10.20 EX-10.20: Form of Senior Management Non-qualified Stock Option Agreement
- 10.21 EX-10.21: Form of Senior Management Restricted Stock Agreement
- 10.22 EX-10.22: Form of Senior Management Performance Share Agreement
- 10.23 EX-10.23: Form of Board of Directors Non-qualified Stock Option Agreement
- 10.24 EX-10.24: License Agreement
- 10.25 EX-10.25: Supply Agreement
- 21.1 EX-21.1: Subsidiaries
- 23.1 EX-23.1: Consent of Grant Thornton LLP
- 23.2 EX-23.2: Consent of Mcgladrey & Pullen LLP
- 31.1 EX-31.1: Certification
- 31.2 EX-31.2: Certification
- 32.1 EX-32.1: Certification
- 32.2 EX-32.2: Certification
Related press release
SVNT similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Savient Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2006 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian J. Hayden, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | ||
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| By: | /s/ Brian J. Hayden | |||
| Brian J. Hayden | ||||
| Senior Vice President and Chief Financial Officer | ||||
March 16, 2007